← Back to Search

Walking Environments for Prediabetes

N/A
Recruiting
Led By Mark Pereira, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 25-64 years old
Classified as overweight or obese with BMI 20.0-39.9 kg/m2
Must not have
BMI below 20 or equal to or above 40
Age below 25 or above 64 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 18 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effects of walking in urban green spaces compared to urban built environments on adults with prediabetes. The study will investigate the potential benefits of exposure to nature, such as increased

Who is the study for?
Adults aged 25-64 with prediabetes, classified as overweight or obese (BMI 20.0-39.9), who exercise less than 100 minutes per week and have stable weight for the last three months can join this trial. They must not be pregnant or breastfeeding, willing to keep their diet and exercise habits except for study requirements, own a smartphone, and pass a health questionnaire.
What is being tested?
The trial is testing the effects of walking in different environments on adults with prediabetes by comparing walks in urban green spaces ('Green Walk') versus built-up city areas ('Gray Walk'). It aims to see which setting might better reduce stress and improve health indicators like heart rate variability.
What are the potential side effects?
Since the interventions involve walking in different environments, side effects may include typical physical activity-related issues such as muscle soreness or fatigue. There's also potential exposure to air pollution during 'Gray Walks' that could affect respiratory health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 25 and 64 years old.
Select...
My BMI is between 20.0 and 39.9, classifying me as overweight or obese.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My BMI is either below 20 or 40 and above.
Select...
I am either younger than 25 or older than 64.
Select...
I have diabetes or take medication for it.
Select...
I have a history of heart disease or am on heart medication.
Select...
I am planning to have major surgery or have had weight loss surgery recently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 18 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measure of Anxiety
Mood assessment
Perceived stress assessment
Secondary study objectives
Ambient Particulate Matter
Black Carbon levels
CMD risk
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Green Walking then Gray WalkingExperimental Treatment2 Interventions
Prediabetics randomized to Green walk first then Gray walk.
Group II: Gray Walking then Green WalkingExperimental Treatment2 Interventions
Prediabetics randomized to Gray walk first then Green walk.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,434 Previous Clinical Trials
1,621,486 Total Patients Enrolled
Mark Pereira, PhDPrincipal InvestigatorUniversity of Minnesota
1 Previous Clinical Trials
4,800 Total Patients Enrolled
Mark PereiraPrincipal InvestigatorUniversity of Minnesota
~144 spots leftby Nov 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top